Related Experiment Video
Updated: Jul 19, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Plasma-soluble CD40 is related to cholesterol metabolism in patients with moderate hypercholesterolemia
Mari Luomala1, Hannu Päivä, Reijo Laaksonen
1Laboratory of Atherosclerosis Genetics, Centre for Laboratory Medicine, Department of Clinical Chemistry, Tampere and Medical School, Tampere University HospitalUniversity of Tampere, P.O. Box 2000, FI-33521, Finland. mari.luomala@uta.fi
Insights
Soluble CD40 (sCD40) levels correlate with cholesterol metabolism markers, suggesting a link between immune activation and cholesterol synthesis. Statins did not alter sCD40 levels in this study.
Area of Science:
- Immunology
- Cardiovascular Research
- Metabolic Science
Background:
- CD40 is a marker of immune activation found in atherosclerotic lesions.
- Understanding the interplay between CD40 and cholesterol metabolism is crucial for cardiovascular health.
Purpose of the Study:
- To investigate the association between soluble CD40 (sCD40) levels and cholesterol synthesis pathways.
- To explore the relationship between sCD40 and specific cholesterol metabolites and apolipoproteins.
Main Methods:
- A randomized controlled trial involving 43 subjects assigned to simvastatin, atorvastatin, or placebo for eight weeks.
- Plasma sCD40 levels were measured via ELISA.
- Cholesterol, lathosterol, plant sterols, and 27-hydroxycholesterol were quantified using gas-liquid chromatography-mass spectrometry.
Main Results:
- sCD40 was inversely correlated with the lathosterol to cholesterol ratio (a cholesterol synthesis indicator) and apolipoprotein A-I.
- sCD40 showed a direct correlation with 27-hydroxycholesterol.
- Multivariate analysis indicated these factors explained 37% of sCD40 variability; statin treatment did not significantly affect sCD40 levels.
Conclusions:
- The findings indirectly suggest a relationship between sCD40 concentrations and cellular cholesterol levels.
- This study highlights a potential novel link between immunological processes and cholesterol metabolism.
Objectives:
CD40 is a marker of immunological activation and is expressed in the atherosclerotic lesions. We studied whether CD40 and cholesterol synthesis pathways are associated with each other.
Design:
Forty-three subjects were randomly assigned to receive either simvastatin (n = 14), atorvastatin (n = 15), or placebo (n = 14) for eight weeks. Plasma samples were obtained before and at the end of the follow-up. sCD40 levels were measured in duplicate using an enzyme-linked immunosorbent assay. Cholesterol, its precursor lathosterol, the plant sterols campesterol and sitosterol as well as 27-hydroxycholesterol were quantified by gas-liquid chromatography-mass spectrometry.
Results:
sCD40 was inversely correlated with the lathosterol to cholesterol ratio (r = - 0.47, p = 0.002), an indicator of cholesterol synthesis rate, as well as apolipoprotein A-I (r = - 0.38, p = 0.01) in addition to being directly correlated with 27-hydroxycholesterol (r = 0.40, p = 0.008). In multivariate linear regression analysis these three predictors explained 37% of the total variability of sCD40 levels. Simvastatin or atorvastatin treatment had no significant effect on sCD40 levels.
Conclusion:
These results indirectly suggest that sCD40 concentrations are related to cellular cholesterol levels. This may be a novel indication for the relationship between immunological processes and cholesterol metabolism.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Atherosclerosis III: Management
Inflammation
